This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kupersmith, M. J. Articles by Chase, N. E. Search for Related Content PubMed PubMed Citation Articles by Kupersmith, M. J. Articles by Chase, N. E.

Stroke, Vol 10, 299-305, Copyright © 1979 by American Heart Association

ARTICLES

Isoproterenol treatment of visual symptoms in migraine

MJ Kupersmith, WK Hass and NE Chase

Six patients with transient or permanent visual loss associated with migraine are presented. In 3 patients with monocular and one patient with binocular episodes of transient visual loss subsequent visual episodes were relieved by prompt inhalation of isoproterenol. The authors review the possible mechanisms of action of isoproterenol in migraine and present evidence to support the prophylactic use of isoproterenol to prevent transient and possible persistent visual loss in patients with migraine.

This article has been cited by other articles:

				J. Winterkorn, M. J. Kupersmith, J. D. Wirtschafter, and S. Forman Treatment of Vasospastic Amaurosis Fugax with Calcium-Channel Blockers N. Engl. J. Med., August 5, 1993; 329(6): 396 - 398. [Full Text]